Hosted on MSN1mon
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15Dr Reddy’s CEO Erez Israeli stated: “We are pleased to collaborate with Henlius to make this daratumumab biosimilar ... a GlobalData owned brand. The information on this site has been included ...
Daratumumab, hyaluronidase-fihj; 1800mg/30000units; per vial; soln for SC inj; preservative-free. Daratumumab binds to CD38 and inhibits the growth of CD38 expressing tumor cells by inducing ...
The addition of subcutaneous daratumumab to triplet therapy improved outcomes in transplant-ineligible or -deferred multiple myeloma. The regimen reduced risk for disease progression or death by 43%.
Suggested remit: To appraise the clinical and cost effectiveness of daratumumab with bortezomib, lenalidomide and dexamethasone within its marketing authorisation for untreated multiple myeloma when ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results